Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma

Clinical trial NCT01144455 · COMPLETED

Trial details

NCT number: NCT01144455
Sponsor: ImmunoGenesis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma

Start date: 2010-06-01
Primary completion: 2013-09-01
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.